NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | -0.23 | $2M | -$1M |
| 2026 Q2 | -0.25 | $2M | -$1M |
| 2025 Q1 | -0.17 | $3M | -$3M |
| 2025 Q4 | -0.26 | $3M | -$2M |
| 2025 Q3 | -0.19 | $2M | -$2M |
| 2025 Q2 | -0.44 | $1M | -$59,315 |
| 2024 Q1 |
| 0.35 |
| $3M |
| $183,633 |
| 2024 Q4 | 2.04 | $272,284 | -$3M |